English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/212858
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey

AuthorsIdelevich, E. A.; Seifert, H.; Sundqvist, M.; Scudeller, L.; Amit, S.; Balode, A.; Bilozor, A.; Drevinek, P.; Kocak Tufan, Z.; Koraqi, A.; Lamy, B.; Marekovic, I.; Miciuleviciene, J.; Mueller-Premru, Manica; Pascual, Álvaro; Pournaras, S.; Saegeman, V.; Schonheyder, H. C.; Schrenzel, J.; Strateva, T.; Tilley, R.; Wiersinga, W. J.; Zabicka, D.; Carmeli, Yehuda; Becker, K.
KeywordsAntimicrobial susceptibility testing
Blood culture
Bloodstream infection
Identification
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
Microbiological diagnostics
Molecular methods
Preanalytics
Rapid diagnostics
Transport
Issue Date2019
PublisherElsevier
CitationClinical Microbiology and Infection 25(11): 1399-1407 (2019)
Abstract[Objectives] High-quality diagnosis of bloodstream infections (BSI) is important for successful patient management. As knowledge on current practices of microbiological BSI diagnostics is limited, this project aimed to assess its current state in European microbiological laboratories. [Methods] We performed an online questionnaire-based cross-sectional survey comprising 34 questions on practices of microbiological BSI diagnostics. The ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES) was the primary platform to engage national coordinators who recruited laboratories within their countries. [Results] Responses were received from 209 laboratories in 25 European countries. Although 32.5% (68/209) of laboratories only used the classical processing of positive blood cultures (BC), two-thirds applied rapid technologies. Of laboratories that provided data, 42.2% (78/185) were able to start incubating BC in automated BC incubators around-the-clock, and only 13% (25/192) had established a 24-h service to start immediate processing of positive BC. Only 4.7% (9/190) of laboratories validated and transmitted the results of identification and antimicrobial susceptibility testing (AST) of BC pathogens to clinicians 24 h/day. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry from briefly incubated sub-cultures on solid media was the most commonly used approach to rapid pathogen identification from positive BC, and direct disc diffusion was the most common rapid AST method from positive BC. [Conclusions] Laboratories have started to implement novel technologies for rapid identification and AST for positive BC. However, progress is severely compromised by limited operating hours such that current practice of BC diagnostics in Europe complies only partly with the requirements for optimal BSI management.
DescriptionOn behalf of theESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES).
Publisher version (URL)https://doi.org/10.1016/j.cmi.2019.03.024
URIhttp://hdl.handle.net/10261/212858
Identifiersdoi: 10.1016/j.cmi.2019.03.024
issn: 1198-743X
e-issn: 1469-0691
Appears in Collections:(IBIS) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.